Nutritional Health LTP Fund General Partner LLC
Insider CIK 1780951 · MCRB 10% owner · EVLO 10% owner · KLDO 10% owner · OMGA 10% owner · GENB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,109,704 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 843,881 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,109,704 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,265,822 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,531,644 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,265,822 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,953,586 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,500,000 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 17,016,215 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 18,483,785 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 4,340,252 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 15,264,724 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 2,777,752 | — | $0 | 2,777,752 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 2,777,752 | — | $0 | 2,777,752 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 1,562,500 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 13,702,224 | — | $0 | 13,702,224 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 12,723,940 | — | $0 | 12,723,940 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 987,491 | — | $0 | 987,491 | SEC↗ |
| GENB Generate Biomedicines, Inc | A Award deriv | 2026-02-26 | 2026-03-02 | 29,561 | — | $0 | 29,561 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2023-07-11 | 2023-07-13 | 1,082,251 | $2.31 | $2.50M | 1,493,241 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2023-07-11 | 2023-07-13 | 3,246,753 | $2.31 | $7.50M | 3,931,685 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2023-07-11 | 2023-07-13 | 1,082,251 | $2.31 | $2.50M | 1,461,795 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | P Buy | 2022-07-05 | 2022-07-07 | 2,912,748 | $3.15 | $9.18M | 5,875,711 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | P Buy | 2022-07-05 | 2022-07-07 | 5,825,495 | $3.15 | $18.35M | 5,825,495 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 4,383,561 | $1.46 | $6.40M | 7,590,873 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 13,698,630 | $1.46 | $20.00M | 13,698,630 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 1,369,863 | $1.46 | $2.00M | 5,495,324 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 1,095,890 | $1.46 | $1.60M | 1,887,419 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 6,849,315 | $1.46 | $10.00M | 8,219,791 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 13,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 2,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 22,275,232 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 4,112,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,666 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 27,388,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 970,588 | — | $0 | 970,588 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,323,529 | — | $0 | 1,323,529 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 661,764 | $17.00 | $11.25M | 5,514,707 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 4,852,943 | — | $0 | 4,852,943 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 294,117 | $17.00 | $5.00M | 1,617,646 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 220,588 | $17.00 | $3.75M | 8,617,413 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 8,396,825 | — | $0 | 8,396,825 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 5,896,386 | — | $0 | 5,896,386 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,088,470 | — | $0 | 1,088,470 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2021-05-17 | 2021-05-19 | 295,171 | — | $0 | 2,962,963 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2021-02-08 | 2021-02-10 | 71,667 | $11.50 | $824.2K | 738,333 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2021-02-08 | 2021-02-10 | 71,667 | $11.50 | $824.2K | 2,982,639 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2021-02-08 | 2021-02-10 | 71,666 | $11.50 | $824.2K | 1,685,444 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 37,143 | $15.00 | $557.1K | 1,370,476 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 46,429 | $15.00 | $696.4K | 4,125,461 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 37,143 | $15.00 | $557.1K | 3,207,312 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 9,285 | $15.00 | $139.3K | 791,529 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 3,587,820 | — | $0 | 4,434,600 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 642,180 | — | $0 | 1,283,282 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 966,234 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 1,186,310 | — | $0 | 3,258,134 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 1,481,481 | — | $0 | 2,962,963 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2020-11-23 | 2020-11-25 | 43,154 | — | $0 | 0 | SEC↗ |